Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-07 Sale |
2025-04-08 4:45 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,002 | $12.3 | $615,075 | 285,963 (Direct) |
View |
| 2025-03-20 Sale |
2025-03-21 6:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 582,284 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 5:12 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $11.21 | $560,446 | 408,074 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 4:35 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $12.31 | $615,565 | 334,410 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-07 6:24 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $11.1 | $555,065 | 219,410 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-19 4:20 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $11.67 | $1,167,100 | 10,105,694 (Indirect Direct) |
View |
| 2024-12-17 Sale |
2024-12-19 4:20 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $11.67 | $1,167,100 | 10,105,694 (Indirect Direct) |
View |
| 2024-12-12 Sale |
2024-12-13 7:53 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,605 | $12.23 | $1,768,093 | 310,888 (Direct) |
View |
| 2024-12-11 Sale |
2024-12-13 7:52 pm |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
40,000 | $12.35 | $493,859 | 74,680 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 5:41 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
50,000 | $13.15 | $657,625 | 136,380 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-11 6:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $13.16 | $1,316,420 | 10,256,647 (Indirect Direct) |
View |
| 2024-12-10 Sale |
2024-12-11 6:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $13.16 | $1,316,420 | 10,256,647 (Indirect Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 7:15 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,640 | $14.11 | $2,041,200 | 436,020 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 9:45 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
90,000 | $13.43 | $1,208,619 | 334,280 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 9:40 pm |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
200,000 | $13.44 | $2,688,751 | 368,852 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 9:40 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14.04 | $140,423 | 1,181,152 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 4:11 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
100,000 | $14.12 | $1,411,742 | 136,380 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $13.95 | $1,394,960 | 10,218,153 (Indirect Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $13.95 | $1,394,960 | 10,218,153 (Indirect Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $16.85 | $1,684,642 | 10,369,106 (Indirect Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $16.85 | $1,684,642 | 10,369,106 (Indirect Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 8:16 pm |
ARS Pharmaceuticals Inc. | SPRY | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. 10% Owner |
563,270 | $18.01 | $10,143,706 | 5,257,328 (Indirect) |
View |
| 2024-10-16 Sale |
2024-10-17 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $16 | $200,000 | 815,529 (Indirect Direct) |
View |
| 2024-10-15 Sale |
2024-10-17 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $14.88 | $1,487,595 | 10,368,153 (Indirect Direct) |
View |
| 2024-10-15 Sale |
2024-10-17 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $14.88 | $1,487,595 | 10,368,153 (Indirect Direct) |
View |
| 2024-10-08 Sale |
2024-10-10 4:28 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $13.83 | $1,382,775 | 10,519,106 (Indirect Direct) |
View |
| 2024-10-08 Sale |
2024-10-10 4:27 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $13.83 | $1,382,775 | 10,519,106 (Indirect Direct) |
View |
| 2024-09-18 Sale |
2024-09-19 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 600,281 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 4:29 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $12.93 | $1,293,205 | 10,518,153 (Indirect Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 4:26 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $12.93 | $1,293,205 | 10,518,153 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 4:25 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $11.5 | $1,149,775 | 10,669,106 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-07 Exercise |
2025-04-08 4:45 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,002 | $4.85 | 285,963 (Direct) |
View |
| 2025-04-07 Exercise |
2025-04-08 4:45 pm |
N/A 2032-01-31 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,002 | $0 | 285,963 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-21 6:30 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 582,284 (Direct) |
View |
| 2025-03-20 Exercise |
2025-03-21 6:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 582,284 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:12 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $4.85 | 408,074 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:12 pm |
N/A 2032-01-31 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $0 | 408,074 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-04 4:35 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
40,936 | $4.85 | 334,410 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-04 4:35 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
9,064 | $3.15 | 334,410 (Direct) |
View |
| 2025-02-03 Exercise |
2025-02-04 4:35 pm |
N/A 2032-05-01 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $0 | 334,410 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-07 6:24 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $3.15 | 219,410 (Direct) |
View |
| 2025-01-06 Exercise |
2025-01-07 6:24 pm |
N/A 2032-05-01 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
50,000 | $0 | 219,410 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer |
152,300 | $0 | 152,300 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
261,900 | $0 | 261,900 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
1,029,500 | $0 | 1,029,500 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
1,029,500 | $0 | 1,029,500 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
274,100 | $0 | 274,100 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
176,700 | $0 | 176,700 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
152,300 | $0 | 152,300 (Direct) |
View |
| 2024-12-12 Exercise |
2024-12-13 7:53 pm |
N/A 2029-07-04 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,605 | $0 | 310,888 (Direct) |
View |
| 2024-12-12 Exercise |
2024-12-13 7:53 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
117,333 | $0.84 | 310,888 (Direct) |
View |
| 2024-12-13 Exercise |
2024-12-13 7:53 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
27,272 | $1.44 | 310,888 (Direct) |
View |
| 2024-12-11 Exercise |
2024-12-13 7:52 pm |
N/A 2028-11-28 |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
40,000 | $0 | 74,680 (Direct) |
View |
| 2024-12-11 Exercise |
2024-12-13 7:52 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
40,000 | $0.64 | 74,680 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:41 pm |
N/A 2029-07-04 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
50,000 | $0 | 136,380 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:41 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
50,000 | $0.84 | 136,380 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-09 5:43 pm |
N/A 2031-12-13 |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
37,541 | $0 | 13,050,073 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-09 5:43 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
11,876 | $8.42 | 13,050,073 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-09 5:43 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
13,789 | $1.44 | 13,050,073 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-09 5:25 pm |
N/A 2033-01-02 |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
37,541 | $0 | 13,050,073 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-09 5:25 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
11,876 | $8.42 | 13,050,073 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-09 5:25 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
13,789 | $1.44 | 13,050,073 (Indirect) |
View |
| 2024-12-04 Exercise |
2024-12-06 7:15 pm |
N/A 2029-07-04 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,640 | $0 | 436,020 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 7:15 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,640 | $0.84 | 436,020 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:45 pm |
N/A 2029-12-16 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
90,000 | $0 | 334,280 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:45 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
90,000 | $0.84 | 334,280 (Direct) |
View |
| 2024-12-03 Exercise |
2024-12-04 9:40 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
77,150 | $3.15 | 368,852 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A 2030-04-28 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
200,000 | $0 | 368,852 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
122,850 | $1.27 | 368,852 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 1,181,152 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:40 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 1,181,152 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-17 4:30 pm |
N/A 2032-02-29 |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $0 | 815,529 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-17 4:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $1.5 | 815,529 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-19 4:30 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 600,281 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-19 4:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 600,281 (Direct) |
View |